Attenuated diuresis and natriuresis in response to glucagon-like peptide-1 in hypertensive rats are associated with lower expression of the glucagon-like peptide-1 receptor in the renal vasculature-Reference-Cited by-同舟云学术

Attenuated diuresis and natriuresis in response to glucagon-like peptide-1 in hypertensive rats are associated with lower expression of the glucagon-like peptide-1 receptor in the renal vasculature

Published:2017-09 Issue: Volume:811 Page:38-47
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Savignano Fernanda A.,Crajoinas Renato O.,Pacheco Bruna P.M.,Campos Luciene C.G.,Shimizu Maria Heloisa M.,Seguro Antonio Carlos,Girardi Adriana C.C.

Funder

Fundação de Amparo à Pesquisa do Estado de São Paulo

Publisher

Elsevier BV

Subject

Pharmacology

Reference53 articles.

1. Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways;Ban;Circulation,2008

2. Regulation of Na+/H+ exchanger NHE3 by glucagon-like peptide 1 receptor agonist exendin-4 in renal proximal tubule cells;Carraro-Lacroix;Am. J. Physiol. Ren. Physiol.,2009

3. Interactions of cAMP-mediated vasodilators with angiotensin II in rat kidney during hypertension;Chatziantoniou;Am. J. Physiol.,1993

4. Defective G protein activation of the cAMP pathway in rat kidney during genetic hypertension;Chatziantoniou;Proc. Natl. Acad. Sci. USA,1995

5. Posttranslational mechanisms associated with reduced NHE3 activity in adult vs. young prehypertensive SHR;Crajoinas;Am. J. Physiol. Ren. Physiol.,2010

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natriuretic peptide system in hypertension: Current understandings of its regulation, targeted therapies and future challenges;European Journal of Pharmacology;2024-08

2. Transforming Diabetes Care: The Molecular Pathways through Which GLP1-RAs Impact the Kidneys in Diabetic Kidney Disease;Biomedicines;2024-03-14

3. In vivo mapping of hemodynamic responses mediated by tubuloglomerular feedback in hypertensive kidneys;Scientific Reports;2023-12-11

4. Renoprotective effects of GLP-1 receptor agonists and SGLT-2 inhibitors—is hemodynamics the key point?;American Journal of Physiology-Cell Physiology;2023-07-01

5. The blood pressure lowering effects of glucagon-like peptide-1 receptor agonists: A mini-review of the potential mechanisms;Current Opinion in Pharmacology;2023-04